USA-based MedImmune, which is owned by AstraZeneca, has made several new appointments, including: Alexander Zukiwski, who has been hired as senior vice president of clinical research; Timothy Hahn joins as vice president of antibody manufacturing; Timothy Maines becomes vice president of corporate quality assurance; Max Donley is named vice president of human resources; Jonathan Klein-Evans becomes vice president of intellectual property; and Paul Williams will take charge of sales operations as vice president.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze